KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Common Equity (2016 - 2025)

Historic Common Equity for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $2.4 billion.

  • Exact Sciences' Common Equity fell 4.98% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 billion, marking a year-over-year decrease of 4.98%. This contributed to the annual value of $2.4 billion for FY2025, which is 4.98% down from last year.
  • Latest data reveals that Exact Sciences reported Common Equity of $2.4 billion as of Q4 2025, which was down 4.98% from $2.5 billion recorded in Q3 2025.
  • Exact Sciences' Common Equity's 5-year high stood at $3.6 billion during Q1 2021, with a 5-year trough of $2.4 billion in Q1 2025.
  • Over the past 5 years, Exact Sciences' median Common Equity value was $3.1 billion (recorded in 2023), while the average stood at $3.0 billion.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 5153.46% in 2021, then tumbled by 2362.43% in 2024.
  • Quarter analysis of 5 years shows Exact Sciences' Common Equity stood at $3.4 billion in 2021, then decreased by 10.17% to $3.0 billion in 2022, then increased by 3.36% to $3.1 billion in 2023, then decreased by 23.62% to $2.4 billion in 2024, then fell by 0.05% to $2.4 billion in 2025.
  • Its Common Equity was $2.4 billion in Q4 2025, compared to $2.5 billion in Q3 2025 and $2.5 billion in Q2 2025.